Christine Murray Resigns from Eiger Biopharmaceuticals Board
Company Announcements

Christine Murray Resigns from Eiger Biopharmaceuticals Board

The latest update is out from Eiger Biopharmaceuticals (EIGR).

Christine A. Murray has announced her resignation from the Board of Directors of Eiger BioPharmaceuticals, effective March 15, 2024. Her decision to step down is not due to any disagreements with the company’s operations, policies, or practices.

For a thorough assessment of EIGR stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyTwo option delistings on April 12th
TheFlyBiotech Alert: Searches spiking for these stocks today
TipRanks Auto-Generated NewsdeskEiger BioPharmaceuticals: Bankruptcy, Delisting, and Board Resignation
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App